Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Tics: early-phase trial registry

4 of 6 indexed Tics trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Tics: 6 US clinical trials tracked, 4 recruiting.

Tics is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Utah, running 2 of these trials.

Enrollment posture brief

Registry condition tics

OPEN 4 | RECR 67% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Tics (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Tics

Tics lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tics on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tics is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Tics research.

    University of Utah accounts for 2 of 6 trials (33.3%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Tics trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Tics splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Tics records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Continuous Theta Burst Stimulation (cTBS) Device
1 trials
Habit Reversal Training Behavioral
1 trials
CBIT +sham cTBS Other
1 trials
CBIT +cTBS Other
1 trials
Habit Reversal Training (HRT) Behavioral
1 trials
Comprehensive Behavioral Intervention for Tics (CBIT) Behavioral
1 trials
Repetitive Transcranial Magnetic Stimulation (rTMS) Device
1 trials

US sites by state

Facility locations filed on Tics trials. A trial with sites in several states counts in each.

Utah 2 trials
Minnesota 2 trials
North Carolina 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tics page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tics condition card totals 6 registered trials; most-linked intervention Continuous Theta Burst Stimulation (cTBS); top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.